MedTrace Logo

Weekly TP-HDFL in the Treatment of Advanced TCC

NCT00154687 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2007-07-31

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy of Weekly TP-HDFL in advanced transitional cell carcinoma in terms of response rate and overall survival.

Conditions

  • Transitional Cell Carcinoma

Interventions

DRUG

Paclitaxel, Cisplatin, 5-Fluorouracil

Sponsors & Collaborators

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Chih-Hung Hsu, M.D.,Ph.D. · Department of Oncology , National Taiwan University Hospital

  • Ann-Lii Cheng, M.D.,Ph.D · Department of Oncology, National Taiwan University Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-10-31
Completion
2004-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00154687 on ClinicalTrials.gov